Comgest Global Investors S.A.S. reduced its stake in Cavium, Inc. (NASDAQ:CAVM) by 47.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,400 shares of the semiconductor provider’s stock after selling 22,300 shares during the period. Comgest Global Investors S.A.S.’s holdings in Cavium were worth $1,749,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. FMR LLC raised its stake in shares of Cavium by 14.6% in the fourth quarter. FMR LLC now owns 10,050,510 shares of the semiconductor provider’s stock valued at $627,554,000 after buying an additional 1,277,223 shares in the last quarter. Jennison Associates LLC raised its stake in shares of Cavium by 40.8% in the third quarter. Jennison Associates LLC now owns 1,718,578 shares of the semiconductor provider’s stock valued at $100,021,000 after buying an additional 498,023 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Cavium by 14.4% in the fourth quarter. Franklin Resources Inc. now owns 1,369,819 shares of the semiconductor provider’s stock valued at $85,532,000 after buying an additional 172,116 shares in the last quarter. Northern Trust Corp raised its stake in shares of Cavium by 15.1% in the third quarter. Northern Trust Corp now owns 1,237,806 shares of the semiconductor provider’s stock valued at $72,041,000 after buying an additional 162,169 shares in the last quarter. Finally, Chartwell Investment Partners LLC raised its stake in shares of Cavium by 452.9% in the third quarter. Chartwell Investment Partners LLC now owns 969,063 shares of the semiconductor provider’s stock valued at $56,399,000 after buying an additional 793,808 shares in the last quarter.

Institutional Ownership by Quarter for Cavium (NASDAQ:CAVM)

Shares of Cavium, Inc. (CAVM) traded down 0.83% during trading on Friday, reaching $66.07. 874,507 shares of the company traded hands. Cavium, Inc. has a 52 week low of $35.90 and a 52 week high of $76.26. The company’s market capitalization is $4.48 billion. The company’s 50-day moving average price is $71.19 and its 200-day moving average price is $67.55.

Cavium (NASDAQ:CAVM) last released its earnings results on Wednesday, April 26th. The semiconductor provider reported $0.20 EPS for the quarter, missing analysts’ consensus estimates of $0.29 by $0.09. Cavium had a positive return on equity of 4.05% and a negative net margin of 26.52%. The firm had revenue of $229.58 million for the quarter, compared to the consensus estimate of $227.22 million. During the same quarter in the previous year, the business posted $0.25 EPS. Cavium’s revenue was up 125.3% on a year-over-year basis. Equities research analysts forecast that Cavium, Inc. will post $2.78 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece of content was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/06/16/cavium-inc-cavm-shares-sold-by-comgest-global-investors-s-a-s-updated-updated.html.

Several analysts have commented on CAVM shares. Morgan Stanley lifted their price objective on shares of Cavium from $75.00 to $80.00 and gave the stock an “overweight” rating in a research report on Friday, April 28th. Longbow Research started coverage on shares of Cavium in a research report on Friday, June 9th. They issued a “buy” rating and a $85.00 price objective on the stock. Argus lifted their price objective on shares of Cavium from $75.00 to $82.00 and gave the stock a “buy” rating in a research report on Tuesday, March 14th. Bank of America Corporation raised shares of Cavium from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $72.00 to $85.00 in a research report on Thursday, February 16th. Finally, Zacks Investment Research lowered shares of Cavium from a “buy” rating to a “hold” rating in a research report on Friday, February 17th. Eight research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Cavium has an average rating of “Buy” and a consensus target price of $72.79.

In other Cavium news, SVP Vincent P. Pangrazio sold 15,000 shares of the stock in a transaction that occurred on Tuesday, May 16th. The shares were sold at an average price of $75.73, for a total transaction of $1,135,950.00. Following the completion of the sale, the senior vice president now directly owns 60,039 shares of the company’s stock, valued at approximately $4,546,753.47. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Arthur D. Chadwick sold 40,000 shares of the stock in a transaction that occurred on Tuesday, May 16th. The shares were sold at an average price of $75.14, for a total transaction of $3,005,600.00. Following the sale, the vice president now directly owns 75,383 shares of the company’s stock, valued at $5,664,278.62. The disclosure for this sale can be found here. 4.65% of the stock is currently owned by company insiders.

About Cavium

Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.

Receive News & Stock Ratings for Cavium Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium Inc. and related stocks with our FREE daily email newsletter.